Search
Life Sciences
Enterome SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce the launch of a Phase 1 clinical study with its...
MaaT Pharma ODYSSEE Study focuses in prevention of dysbiosis complications with autologous fecal microbiota transplantation in Acute Myeloid Leukemia patients undergoing...
Major treatments such as high-dose antibiotic therapies and chemotherapies can lead to serious complications and create a gut microbiota imbalance (formerly called intestinal...
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they...
ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C...
TargEDys, an innovator in appetite regulation, announces a €5.8M “Series A” fundraising round based on world-leading research from company founders Serguei Fetissov and...
Cambrooke Therapeutics, Inc. (“Cambrooke”), a global therapeutic nutrition innovator, is pleased to announce the closing of the Series C investment round, led by Seventure...
MaaT Pharma, a reference for the microbiome industry, is announcing a significant €10 million fundraising operation within the context of its series A. This will notably...
Seventure, one of Europe’s leaders in financing innovation, has received further investment in its Health for Life Capital™, the largest fund worldwide that focusses...
Seventure Partners, one of Europe’s leaders in financing innovation, announces today its investment in MaaT Pharma™, a newly founded French microbiome company. Seventure...
